These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3050587)

  • 1. Magnetic resonance imaging in the evaluation of treatment in multiple sclerosis.
    Kappos L; Städt D; Ratzka M; Keil W; Schneiderbanger-Grygier S; Heitzer T; Poser S; Nadjmi M
    Neuroradiology; 1988; 30(4):299-302. PubMed ID: 3050587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
    Kappos L
    Schriftenr Neurol; 1990; 32():1-200. PubMed ID: 2200108
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study.
    Kappos L; Patzold U; Dommasch D; Poser S; Haas J; Krauseneck P; Malin JP; Fierz W; Graffenried BU; Gugerli US
    Ann Neurol; 1988 Jan; 23(1):56-63. PubMed ID: 3278672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trials of immunosuppression and immunomodulation in multiple sclerosis.
    Kappos L
    J Neuroimmunol; 1988 Dec; 20(2-3):261-8. PubMed ID: 3058744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reproducible repositioning method for serial magnetic resonance imaging studies of the brain in treatment trials for multiple sclerosis.
    Gallagher HL; MacManus DG; Webb SL; Miller DH
    J Magn Reson Imaging; 1997; 7(2):439-41. PubMed ID: 9090605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
    Schluep M; Steck AJ; Despland PA; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Rundsch Med Prax; 1991 Jun; 80(24):670-2. PubMed ID: 2068440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic options in multiple sclerosis: present and future.
    Steck AJ; Burger D; Bourdenet S; Regli F; Ochsner F; Berrut E; Gauthier G
    Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):135-6. PubMed ID: 1710387
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative clinical trial of cyclosporine in multiple sclerosis: the pros.
    Dommasch D
    Neurology; 1988 Jul; 38(7 Suppl 2):28-9. PubMed ID: 3290711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic trials in multiple sclerosis.
    Noseworthy JH; Seland TP; Ebers GC
    Can J Neurol Sci; 1984 Aug; 11(3):355-62. PubMed ID: 6205737
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
    Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E
    Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine versus azathioprine in the treatment of multiple sclerosis: 12-month clinical and immunological evaluation.
    Steck AJ; Regli F; Ochsner F; Gauthier G
    Eur Neurol; 1990; 30(4):224-8. PubMed ID: 2209678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy of multiple sclerosis: the use of magnetic resonance imaging in the evaluation of clinical trials].
    Ozawa K; Saida T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1501-3. PubMed ID: 8752444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG.
    Zhou Y; Huang Q; Lu T; Sun X; Fang L; Lu Z; Hu X; Kermode A; Qiu W
    J Clin Neurosci; 2017 Apr; 38():71-73. PubMed ID: 28111033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in the evaluation of clinical trials in multiple sclerosis.
    Paty DW; Li DK; Oger JJ; Kastrukoff L; Koopmans R; Tanton E; Zhao GJ
    Ann Neurol; 1994; 36 Suppl():S95-6. PubMed ID: 8017896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group.
    Lancet; 1988 Jul; 2(8604):179-83. PubMed ID: 2899660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of repositioning on brain MRI lesion load assessment in multiple sclerosis: reliability of subjective quality criteria.
    Rovaris M; Gawne-Cain ML; Sormani MP; Miller DH; Filippi M
    J Neurol; 1998 May; 245(5):273-5. PubMed ID: 9617707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
    Radue EW; O'Connor P; Polman CH; Hohlfeld R; Calabresi P; Selmaj K; Mueller-Lenke N; Agoropoulou C; Holdbrook F; de Vera A; Zhang-Auberson L; Francis G; Burtin P; Kappos L;
    Arch Neurol; 2012 Oct; 69(10):1259-69. PubMed ID: 22751847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuroimaging assessments for research studies (including drug trials) in multiple sclerosis.
    Apperson ML; Agius MA
    Curr Protoc Neurosci; 2011 Jan; Chapter 10():Unit10.4. PubMed ID: 21207365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study.
    Zivadinov R; Medin J; Khan N; Korn JR; Chitnis T; Naismith RT; Alvarez E; Dwyer MG; Bergsland N; Carl E; Silva D; Weinstock-Guttman B;
    Mult Scler Relat Disord; 2019 Jan; 27():65-73. PubMed ID: 30342416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.